Ankang Biotech

Founded in 2007, Ankang Biotechnology Group is headquartered in Shanghai, the international financial center, and owns more than ten subsidiary companies including Ankang (Shanghai) Biotechnology, Shanghai Zheer Gene Technology, Shanghai Huajian Biotechnology, Shanghai Baikang Internet, Yancheng Ankang Biotechnology, Nantong Huadi Biotechnology, Guangzhou Chendi Biotechnology, and Jinan Qiyuan Ankang. Over the past decade or more, Ankang, with the vision of "Technology benefits the world, life is better and healthier," has been proactive and innovative in the three major business fields of "gene technology, health management, and identification services." It has established over 100 one-stop genetic testing service centers across 26 provinces and cities nationwide, initially forming a diversified group strategic development pattern of "Ankang in a hundred cities."
For more than ten years, Ankang has always adhered to product quality first, driven by technology, and has successively established 3 DNA testing and identification laboratories and 2 molecular genetics laboratories with internationally first-class standards. At the same time, it has reached strategic cooperation with several well-known domestic and international authoritative institutions and expert teams, including the Gene Testing Project Team of the Shanghai Institute of Life Sciences, Chinese Academy of Sciences, and the Max Planck Institute in Germany. Currently, the group's technical team has exceeded 70 people, including 5 professional doctors and 13 masters. It not only possesses advanced testing and identification equipment but also the latest genetic analysis system from American ABI and the new-generation high-throughput gene sequencing platform from Illumina, providing support for comprehensively opening up the entire gene industry service chain and achieving full connectivity in research, testing, products, and services, and preparing conditions for building a comprehensive, one-stop, high-quality and efficient service system to innovate and promote the take-off of gene technology and the comprehensive health industry.